Form 4: Berkshire Hathaway Reduces Significant Stake in DaVita Inc. Through Recent Share Sales

Berkshire Hathaway Inc., a prominent 10% owner and director of DaVita Inc., has reported the sale of 200,000 shares of DaVita common stock across multiple transactions in late May 2025.

Summary

• Berkshire Hathaway Inc. and Warren E. Buffett, identified as a 10% owner and director of DaVita Inc. (DVA), reported the disposition of DaVita common stock.
• A total of 200,000 shares of DaVita common stock were sold by Berkshire Hathaway between May 22, 2025, and May 27, 2025.
• The sales were executed at weighted average prices ranging from $137.2775 to $140.1794 per share.
• Following these transactions, Berkshire Hathaway's beneficial ownership in DaVita Inc. stands at 33,796,541 shares.
• The reported transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
• The beneficial ownership includes 17,164,453 shares owned by Government Employees Insurance Company (GEICO), a subsidiary of Berkshire Hathaway Inc., and 16,632,088 shares owned by Berkshire's pension plans (BNSF Master Retirement Trust and Berkshire Hathaway Inc. Consolidated Pension Plan).

Sentiment

Score: 3

Explanation: The sale of 200,000 shares by a highly respected and long-term investor like Berkshire Hathaway, even if pre-planned, typically signals a reduction in conviction or a portfolio rebalancing. This action, while not necessarily indicative of immediate fundamental issues with DaVita, can lead to negative market sentiment and is generally considered a bearish signal from a prominent insider.

Negatives

• The sale of 200,000 shares by a major, long-term investor like Berkshire Hathaway could be interpreted by the market as a reduction in conviction or a strategic portfolio rebalancing.
• While conducted under a pre-arranged plan (Rule 10b5-1(c)), the divestment by a significant 10% owner and director may lead to negative investor sentiment.

Risks

• Investor sentiment risk: Large-scale sales by highly influential investors such as Berkshire Hathaway can negatively impact market perception of DaVita Inc. and potentially exert downward pressure on its stock price.
• Portfolio rebalancing implications: Continued or significant divestment by Berkshire Hathaway could signal a strategic shift away from DaVita, potentially affecting future institutional investment interest in the company.

Future Outlook

The document, an SEC Form 4, is a transactional report and does not contain any forward-looking statements or guidance regarding DaVita Inc.'s future performance or outlook.

Management Comments

• The filing is signed by Warren E. Buffett on behalf of himself and each other reporting person, indicating his direct involvement in the reported transactions and disclosures.

Industry Context

This Form 4 filing reports an insider transaction by a major investor in the healthcare services sector, specifically related to DaVita Inc., a leading provider of kidney care services. While the filing itself does not provide industry-specific trends, the divestment by Berkshire Hathaway could be viewed in the context of their broader portfolio management strategy, which often involves long-term positions in various industries.

Related Party Transactions

• 17,164,453 shares of the total reported securities are owned by Government Employees Insurance Company (GEICO), a subsidiary of Berkshire Hathaway Inc.
• 16,632,088 shares of the total reported securities are owned by Berkshire's pension plans, specifically BNSF Master Retirement Trust (6,100,000 shares) and Berkshire Hathaway Inc. Consolidated Pension Plan (10,532,088 shares).
• Warren E. Buffett disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
• Berkshire Hathaway Inc., Warren E. Buffett, and the aforementioned pension plans disclaim beneficial ownership in the shares held by the pension plans.

Stakeholder Impact

• Shareholders: Existing and potential shareholders may interpret the significant share sales by a major investor like Berkshire Hathaway as a negative indicator, potentially leading to decreased investor confidence and downward pressure on DaVita's stock price.
• Company Management: Management may face increased scrutiny or questions regarding the reasons behind a prominent long-term shareholder's decision to reduce its stake.

Key Dates

Recommendation

Keywords

Berkshire Hathaway, DaVita Inc., DVA, Warren Buffett, SEC Form 4, Insider Transaction, Share Sale, Stock Disposition, Beneficial Ownership, 10b5-1 Plan, Healthcare Services, Dialysis